Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conivaptan in acute decompensated heart failure
NCT00057356Phase 2Completed
- Sponsor
- Cumberland Pharmaceuticals
- Start
- Nov 2002
- Primary completion
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of conivaptan in acute decompensated heart failure (ADHF), sponsored by Cumberland Pharmaceuticals. Started Nov 2002; status: completed.
02
Drugs
conivaptan
03
Conditions
acute decompensated heart failure (ADHF)
Beyond the preview
Go deeper on NCT00057356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057356.